Concepedia

Alba A. Brandes

AA

191

Publications

55.3K

Citations

73

H-Index

1985

Active since

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

European Organisation for Research and Treatment of Cancer

Institute of Neurological Sciences

Azienda USL di Bologna

University of Padua

Alba A. Brandes is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1985–2024

191

Publications

191

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21K citations · Full text

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.7K citations

, , +8

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

Olivier Chinot, Wolfgang Wick, Warren Mason et al. · New England Journal of Medicine · 2014 · 2.4K citations · Full text

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

David A. Reardon, Alba A. Brandes, Antonio Omuro et al. · JAMA Oncology · 2020 · 1.4K citations · Full text

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Martin J. van den Bent, Alba A. Brandes, Martin Taphoorn et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

Rows per page

1–5 of 191